10.5 Female Reproductive Disorders & Gynecology
Key Takeaways
- Pelvic inflammatory disease (PID) is typically polymicrobial (Neisseria gonorrhoeae, Chlamydia trachomatis, and vaginal flora); outpatient therapy is ceftriaxone plus doxycycline with metronidazole, and tubo-ovarian abscess requires hospitalization and possible drainage.
- Polycystic ovary syndrome (PCOS) requires two of three Rotterdam criteria (oligo/anovulation, clinical or biochemical hyperandrogenism, polycystic ovarian morphology); first-line for anovulatory infertility is letrozole, and weight loss plus combined oral contraceptives treat irregular menses and hyperandrogenism.
- Endometriosis classically causes cyclic pelvic pain, dysmenorrhea, and dyspareunia with chocolate cysts; definitive diagnosis is laparoscopic visualization, and first-line medical therapy is continuous combined oral contraceptives or progestins.
- Abnormal uterine bleeding evaluation excludes pregnancy first; structural causes use the PALM-COEIN framework, and postmenopausal bleeding requires endometrial sampling to exclude endometrial cancer.
- Ectopic pregnancy presents with amenorrhea, unilateral pelvic pain, and vaginal bleeding; hemodynamically stable patients with early unruptured ectopic may receive methotrexate, while rupture requires surgical management.
Female Reproductive Disorders on Step 2 CK
The official Step 2 CK content specifications group Renal & Urinary System & Reproductive Systems at 7–13% of items. Female reproductive pathology outside pregnancy is tested heavily within Obstetrics & Gynecology clinical science (10–20% of the exam when combined with obstetric content). Vignettes emphasize diagnosis, first-line pharmacotherapy, surgical indications, and emergency triage.
Pelvic Inflammatory Disease & Tubo-Ovarian Abscess
Pelvic inflammatory disease (PID) is an ascending polymicrobial infection of the upper genital tract involving the endometrium, fallopian tubes, and/or ovaries. Common pathogens include Neisseria gonorrhoeae, Chlamydia trachomatis, and vaginal anaerobes/facultative organisms.
Clinical Diagnosis
Minimum diagnostic criteria (treat empirically if present and no alternative diagnosis is more likely):
- Sexually active patient at risk for STIs
- Pelvic or lower abdominal pain
- Cervical motion tenderness, uterine tenderness, or adnexal tenderness on bimanual exam
Supportive findings include fever, mucopurulent cervical discharge, abundant WBC on wet mount, elevated ESR/CRP, and laboratory documentation of gonorrhea or chlamydia.
Management Algorithm
| Setting | Preferred Regimen | Key Points |
|---|---|---|
| Outpatient PID | Ceftriaxone 500 mg IM once + doxycycline 100 mg PO BID × 14 days + metronidazole 500 mg PO BID × 14 days | Cover gonorrhea, chlamydia, and anaerobes; partner treatment and abstinence until therapy complete |
| Inpatient PID | IV cefotetan or cefoxitin + doxycycline, or clindamycin + gentamicin | Indications: TOA, pregnancy, severe illness, failed outpatient therapy, inability to tolerate PO |
| Tubo-ovarian abscess (TOA) | Hospitalize; IV antibiotics; gynecology consult | Abscess ≥7–9 cm, rupture, or failed medical therapy → drainage/surgery |
Fitz-Hugh–Curtis syndrome is perihepatitis from ascending gonococcal/chlamydial infection presenting as right-upper-quadrant pain with normal LFTs or mild transaminase elevation and "violin-string" adhesions at laparoscopy.
Polycystic Ovary Syndrome (PCOS)
PCOS is the most common endocrine cause of anovulatory infertility. Diagnosis uses Rotterdam criteria (need 2 of 3 after excluding mimics such as nonclassic CAH, hyperprolactinemia, and thyroid disease):
- Oligo-ovulation or anovulation
- Clinical and/or biochemical hyperandrogenism (hirsutism, acne, elevated total/free testosterone)
- Polycystic ovarian morphology on ultrasound (≥20 follicles per ovary or ovarian volume ≥10 mL; not required if other two criteria met)
High-Yield Management
- Lifestyle / weight loss: First intervention in overweight patients; modest weight loss can restore ovulation.
- Menstrual regulation / endometrial protection: Combined oral contraceptives (COCs) are first-line for irregular menses and hyperandrogenism in patients not seeking pregnancy.
- Insulin resistance / diabetes risk: Screen for diabetes; metformin is adjunctive, especially with impaired glucose tolerance.
- Anovulatory infertility: Letrozole is first-line ovulation induction (preferred over clomiphene in many guidelines).
- Anti-androgen therapy: Spironolactone may be added for hirsutism after reliable contraception is established (teratogenic risk).
Endometriosis
Endometriosis is ectopic endometrial glands and stroma outside the uterine cavity, driven by estrogen. Classic symptoms are cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility. Exam may show uterosacral nodularity or fixed retroverted uterus, but physical findings can be normal.
- Ovarian endometrioma ("chocolate cyst"): Complex ovarian cyst with ground-glass appearance on ultrasound.
- Diagnosis: Clinical therapy may begin empirically; definitive diagnosis is laparoscopic visualization (± histologic confirmation).
- Medical therapy: Continuous or cyclic COCs, progestins (norethindrone, medroxyprogesterone, levonorgestrel IUD), or GnRH agonists/antagonists with add-back therapy for refractory pain.
- Surgery: Laparoscopic excision/ablation for failed medical therapy, endometrioma management, or infertility evaluation.
Abnormal Uterine Bleeding (AUB)
Always exclude pregnancy first (urine or serum β-hCG). Structural and nonstructural causes are organized by PALM-COEIN:
| Category | Examples | Step 2 CK Focus |
|---|---|---|
| Polyp | Endometrial/endocervical polyps | Intermenstrual bleeding; hysteroscopic polypectomy |
| Adenomyosis | Endometrial tissue in myometrium | Heavy, painful menses; multiparous patients |
| Leiomyoma (fibroid) | Intramural, submucosal, subserosal | Heavy bleeding, bulk symptoms; myomectomy vs hysterectomy vs UAE |
| Malignancy/hyperplasia | Endometrial cancer, EIN | Postmenopausal bleeding → endometrial biopsy |
| Coagulopathy | vWD, platelet disorders | Adolescent heavy menses at menarche |
| Ovulatory dysfunction | PCOS, thyroid, hyperprolactinemia | Irregular intervals; treat underlying cause |
| Endometrial | Primary endometrial dysfunction | Diagnosis of exclusion |
| Iatrogenic | Anticoagulants, IUDs, hormones | Medication review |
| Not otherwise classified | Rare causes | — |
Postmenopausal bleeding is endometrial cancer until proven otherwise—perform endometrial sampling (office biopsy or hysteroscopy/D&C). Transvaginal ultrasound endometrial thickness ≤4 mm has high negative predictive value but does not replace sampling when clinical suspicion is high or bleeding persists.
Ovarian Emergencies & Ectopic Pregnancy
Ovarian Torsion
Sudden severe unilateral pelvic pain, nausea/vomiting, and adnexal mass (often cyst or dermoid). Doppler ultrasound may show decreased/absent ovarian flow, but normal Doppler does not exclude torsion. Management is emergent surgical detorsion (ovary-sparing when viable), not delay for prolonged imaging.
Ectopic Pregnancy (Non-Obstetric Overlap)
Classic triad: amenorrhea, unilateral abdominal/pelvic pain, vaginal bleeding. Risk factors include prior ectopic, PID/tubal damage, prior tubal surgery, and assisted reproduction.
[ Positive β-hCG + pelvic pain/bleeding ]
|
[ Transvaginal ultrasound ]
|
+-------------------+-------------------+
| |
[ IUP visualized ] [ No IUP / adnexal mass or free fluid ]
| |
[ Manage as IUP ] [ Hemodynamically unstable or rupture? ]
|
+--------------------+--------------------+
| |
[ Yes ] [ No ]
| |
[ Emergent laparoscopy / [ Stable: methotrexate criteria? ]
laparotomy ] |
+--------------+--------------+
| |
[ Meets criteria ] [ Does not meet / refuses ]
| |
[ IM methotrexate ] [ Surgical management ]
+ serial β-hCG follow-up
Methotrexate candidates (typical criteria): hemodynamic stability, no rupture, β-hCG below institutional threshold (commonly <5,000 mIU/mL), ectopic mass usually <3–4 cm, no fetal cardiac activity, normal LFTs/CBC/creatinine, reliable follow-up, and no breastfeeding/immunodeficiency/active pulmonary disease. Absolute contraindications include intrauterine pregnancy, immunodeficiency, baseline blood dyscrasias, active peptic ulcer disease, hepatic/renal dysfunction, and inability to comply with follow-up.
Contraception Counseling Pearls
- Combined hormonal contraceptives: Contraindicated with migraine with aura, prior VTE, smoking age ≥35 with ≥15 cigarettes/day, uncontrolled hypertension, and known thrombophilia.
- Progestin IUD / implant: Highly effective long-acting reversible contraception; levonorgestrel IUD also treats heavy menstrual bleeding and endometriosis-associated pain.
- Copper IUD: Nonhormonal; most effective emergency contraception when placed within 5 days of unprotected intercourse.
- Emergency contraception pills: Levonorgestrel OTC most effective within 72 hours; ulipristal more effective up to 5 days and with higher BMI.
A 22-year-old woman presents with 3 days of lower abdominal pain and fever. She is sexually active with one new partner and uses condoms inconsistently. Temperature is 38.4°C (101.1°F). Pelvic examination reveals mucopurulent cervical discharge and severe cervical motion tenderness. Pregnancy test is negative. She is hemodynamically stable and tolerating oral intake. Which of the following is the most appropriate outpatient regimen?
A 27-year-old woman with oligomenorrhea, acne, and hirsutism has an elevated free testosterone level and polycystic ovarian morphology on ultrasound. Pregnancy test is negative, TSH and prolactin are normal, and she is not currently seeking pregnancy. Which of the following is the most appropriate first-line therapy for menstrual regulation and hyperandrogenism?
A 58-year-old woman who is 7 years postmenopausal presents with a single episode of vaginal bleeding. Speculum examination shows no cervical lesions, and pap testing is up to date and normal. Which of the following is the most appropriate next step?